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Quality assurance
Substantial discoveries at Kansas State University
are sparking innovation for the private sector,
economic growth in the state
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A

recent 40 percent increase in
patents awarded to Kansas State
University — and success in licensing this
technology — shows the university packs a
powerful one-two punch when it comes to
discovery and commercialization.
“Kansas State University is qualityfocused,” said Kent Glasscock, president
of the Kansas State University Institute for
Commercialization. “We have an outstanding
system that takes quality disclosures and
converts them into meaningful partnerships
with companies that take our inventions into
the global marketplace.”
The Kansas State University Research
Foundation and the Kansas State University
Institute for Commercialization work
together to help university researchers
take their ideas and inventions and make
them profitable. The foundation handles
researcher disclosures and the patent process,
and the institute works with companies to
license the new technology.
According to the foundation’s records,
the university averages four to six patents
per year. In 2014, that number rose to 14
patents — but the actual number of patents
awarded to university researchers isn’t
necessarily the focus.
“Kansas State University’s increase
is noticeable in regard to the number of
disclosures and patents awarded, but what
we also are really good at is converting the
patents we generate into licenses that create
revenue,” Glasscock said. “We are ranked
36th in the nation by the Association of
University Technology Managers for licenses
and options to license per 100 disclosures.”
The rankings place Kansas State
University ahead of Harvard University,
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Duke University, Pennsylvania State University, Johns
Hopkins University and Purdue University, among
others, in earning more revenue per licensed patent.

therapies; combining with stem cells to repair or replace
organs; drug delivery; an adjuvant for vaccines; and drug
and cell encapsulation.

In fiscal year 2014, the institute generated $2.4
million in university revenue and $3 million in value of
equity holdings. It also has created 384 jobs in the region
with salaries averaging $57,200.

This hydrogel patent is licensed to PepGel LLC.
The company is an inventor-owned startup and was
chosen by CIO Review as one of its 20 most promising
biotechnology solution providers.

As well as fostering industry growth, these successes
are helping the university with its visionary plan to be a
Top 50 public research university. The K-State 2025 plan
includes increasing intellectual capital from research.

Improving livestock health

“K-State 2025 sets a vision in which Kansas State
University is a center of innovation and research for
the state, the nation and the world,” said Jim Guikema,
Kansas State University Research Foundation president
and associate vice president for research. “To be effective,
the product of research has to have value. If you give
something away freely to everyone, it has no value. If
you tell a company here is something you can make
money on and we can do it together, now it has value.”
Three innovations — among many — benefited
from the Institute for Commercialization and Research
Foundation partnership in 2014.

New opportunities for
biomedicine
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Jim Drouillard, professor of animal sciences and
industry; Tom Herald, food chemist and adjunct
professor of grain science and industry; and Matthew
Greenquist, former graduate student, conducted research
that led to U.S. Patent No. 8,828,421, “Method for
Encapsulation of Orally Ingested Materials to Alter the
Site of Digestion, Site of Action, or Stability.”
The encapsulation is a candy-like coating — visually
similar to peanut brittle — that protects vitamins and
other micronutrients given to cattle and other ruminant
animals from being prematurely digested by bacteria in
the animal’s digestive system. Once the material bypasses
the rumen and ends up in the gastric portion of the
animal’s stomach, strong acids in the stomach dissolve
the coating, releasing the nutrient so the animal can
absorb it.
The patent is licensed to AFGRI Operations Limited,
part of the South African food group AFGRI. The
technology is deployed through AFGRI Animal Feeds,
one of South Africa’s leading animal feed manufacturers.

Xiuzhi “Susan” Sun, university distinguished
professor of grain science and bio- and agro-engineering,
and Hongzhou “John” Huang, a 2012 doctoral
graduate, conducted research that led to U.S. Patent No.
8,835,395, “Novel Protein Peptide Hydrogels.”

Safer pest control

The hydrogels are formed from various combinations
of short peptides — compounds created from amino
acids — and may have numerous biomedical research
uses. They also can be used for medical device
application, such as scaffolds or artificial extracellular
matrix for tissue engineering and healing wounds; cell

Kun Yan Zhu, professor of entomology; Xin Zhang,
research associate in the Division of Biology; and
Jianzhen Zhang, visiting scientist from Shanxi University
in China, conducted research that led to U.S. Patent
8,841,272, “Double-Stranded RNA-Based Nanoparticles
for Insect Gene Silencing.”
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Double-stranded RNA, or dsRNA, is a microscopic,
genetics-based technology that can help safely kill
mosquitos and other insect pests by using a biological
process known as RNA interference, or RNAi, to
destroy the genetic code of an insect in a specific DNA
sequence. The technology can have great potential for
safe and effective control of insect pests without harming
unintended species, such as pets.
The Kansas State University Institute for
Commercialization is working with several companies
interested in obtaining a license to the patent.
By Stephanie Jacques
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